Impax Laboratories to Present at the 31st Annual J.P. Morgan Healthcare
JPMorgan Healthcare Conference 2013
HAYWARD, Calif. -- January 2, 2013
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will
present at the 31^st Annual J.P. Morgan Healthcare Conference on Monday,
January 7, at 3:00 p.m. Pacific Standard Time. The conference will be held at
the Westin St. Francis Hotel, San Francisco, CA.
Individuals may listen to the live or an archived presentation made at the
conference, which will be posted in the investor relations section of the
Company’s web site at www.impaxlabs.com. This presentation will be archived on
the Company’s web site for 30 days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. (Impax) is a technology based specialty
pharmaceutical company applying its formulation expertise and drug delivery
technology to the development of controlled-release and specialty generics in
addition to the development of branded products. Impax markets its generic
products through its Global Pharmaceuticals division and markets its branded
products through the Impax Pharmaceuticals division. Additionally, where
strategically appropriate, Impax has developed marketing partnerships to fully
leverage its technology platform. Impax is headquartered in Hayward,
California, and has a full range of capabilities in its Hayward, Philadelphia
and Taiwan facilities. For more information, please visit the Company's Web
site at: www.impaxlabs.com.
Impax Laboratories, Inc.
Sr. Director, Investor Relations and Corporate Communications
Mark Donohue, 215-558-4526
Press spacebar to pause and continue. Press esc to stop.